Neoadjuvant therapy for pancreatic ductal adenocarcinoma-real effects or patient selection?

Affiliations

Editorial

Stefan Heinrich. Hepatobiliary Surg Nutr. 2018 Aug.

. 2018 Aug;7(4):289-291.

doi: 10.21037/hbsn.2018.03.11.

¹ Department of General, Visceral and Transplantation Surgery, University Hospital of Mainz, Mainz, Germany.

No abstract available

Conflict of interest statement

Conflicts of Interest: The author has no conflicts of interest to declare.

Neoadjuvant therapy prior to surgical resection for previously explored pancreatic cancer patients is associated with improved survival.
Lu F, Soares KC, He J, Javed AA, Cameron JL, Rezaee N, Pawlik TM, Wolfgang CL, Weiss MJ. Lu F, et al. Hepatobiliary Surg Nutr. 2017 Jun;6(3):144-153. doi: 10.21037/hbsn.2016.08.06. Hepatobiliary Surg Nutr. 2017. PMID: 28652997 Free PMC article.

1. Haeno H, Gonen M, Davis MB, et al. Computational modeling of pancreatic cancer reveals kinetics of metastasis suggesting optimum treatment strategies. Cell 2012;148:362-75. 10.1016/j.cell.2011.11.060 - DOI - PMC - PubMed
1. Heinrich S, Lang H. Neoadjuvant Therapy of Pancreatic Cancer: Definitions and Benefits. Int J Mol Sci 2017;18. doi: .10.3390/ijms18081622 - DOI - PMC - PubMed
1. Crippa S, Bittoni A, Sebastiani E, et al. Is there a role for surgical resection in patients with pancreatic cancer with liver metastases responding to chemotherapy? Eur J Surg Oncol 2016;42:1533-9. 10.1016/j.ejso.2016.06.398 - DOI - PubMed
1. Lu F, Soares KC, He J, et al. Neoadjuvant therapy prior to surgical resection for previously explored pancreatic cancer patients is associated with improved survival. Hepatobiliary Surg Nutr 2017;6:144-53. 10.21037/hbsn.2016.08.06 - DOI - PMC - PubMed
1. Mokdad AA, Minter RM, Zhu H, et al. Neoadjuvant Therapy Followed by Resection Versus Upfront Resection for Resectable Pancreatic Cancer: A Propensity Score Matched Analysis. J Clin Oncol 2017;35:515-22. 10.1200/JCO.2016.68.5081 - DOI - PubMed